Cannabis-Based Medicine Trial: Multiple Sclerosis Spasticity

Cannabis-Based Medicine Trial: Multiple Sclerosis Spasticity

A six-week, placebo-controlled clinical trial of an oral spray drug derived from whole cannabis plants (Sativex® — GW Pharmaceuticals, Salisbury, UK) involving 189 individuals with multiple sclerosis showed positive changes in a self-reported measurement of...
Cannabis Treatment: Anorexia and Cachexia

Cannabis Treatment: Anorexia and Cachexia

An appetite enhancing effect of THC is observed with daily divided doses totalling 5 mg. When required, the daily dose may be increased to 20 mg. In a long-term study of 94 AIDS patients, the appetite-stimulating effect of THC continued for months, confirming the...